Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gosogliptin vs Vildagliptin in Type 2 Diabetes
NCT03088670Phase 3Completed
- Sponsor
- SatRx LLC
- Start
- Apr 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gosogliptin in type 2 diabetes mellitus (T2DM), sponsored by SatRx LLC. Started Apr 2013; status: completed.
02
Drugs
gosogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03088670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03088670.